Atlas Trials

Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine

Clinical trial NCT02289248 · COMPLETED

Trial details

NCT number
NCT02289248
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Depression
Start date
2015-02-01
Primary completion
2016-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.